FDA Investigator Joseph Milcetic
Joseph Milcetic has conducted inspections on 38 sites in 1 countries as of 18 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
38
Last Inspection Date:
18 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Joseph Milcetic:
Affiong Flores,
Alia Legaux,
Alice S Tsao,
Althea A Williams,
Andrew F Cohen,
Ann B Okon,
Anna M Alexander,
Anthony R Rauert,
Arduino Frankovic,
Arthur G Hurst,
Arthur S Williams, Jr,
Ashley Polizzotto,
Camille D Monde,
Carolyn J Cook,
Cassandra Gasby,
Christian Parra,
Daniel L Aisen,
David A Carlson,
David A Trent Carlson,
David R Lattuca,
Demitria J Argiropoulos,
Demitria J Xiradakis,
Denise L Terzian,
Diamond M Oden,
Dipesh K Shah,
Donald J Ullstrom,
Donald L Kass,
Douglas G Ng,
Elizabeth H Davis,
Elizabeth H Slazak,
Ellen M Landis,
Emilio Z Azukwu,
Erin L Nagel,
Frank Verni,
Gabriel Feng,
Gregson A Joseph,
Harry J Brewer,
Helen B Ricalde,
Hilary K Wagner,
Isaac N Baah,
Jackson Y See,
Jacqueline S Warner,
James D Bridges,
Jane C Chen,
Jason Kwong,
Joel R Merriman,
Joseph J Vannelli,
Joseph Maselli,
Joy P Matthias,
Judy Keihl,
Juliana Falla,
Julie D Bringger,
Karen L Kosar,
Kevin A Gonzalez,
Kimberley A Ricketts,
Kimberly Y Smithson,
Lauren E Blaser,
Lea M Landi,
Leena Thomas,
Linda M Sacco,
Lirissia Mccoy,
Loretta J Miller,
Marc S Neubauer,
Marie Elena C Puleo,
Marlene L Davis,
Mary M Finn,
Matthew A Spataro,
Melissa N Gregorio,
Mercedes G Castillo,
Meredith P Soehl, Investigator,
Michael A Charles,
Michael R Dominick,
Michael W Burd,
Mikayla K Deardorff,
Milan S Mcgorty,
Mouhamed H Halwani,
Nur M Faisal,
Omotunde O Osunsanmi,
Paul E Stein,
Paul Mouris,
Perez,
Perry T Nichols,
Peter M Trunk,
Peter R Caparelli,
Philip F Istafanos, DMV, MS,
Raymond M Lam,
Rita F Monfort,
Robert E Moncayo,
Samuel A Francis,
Samuel T Walker,
Sarah A Meehan,
Satheesh Thomas,
Simone E Pitts,
Sonia E Ortiz,
Sony Mathews,
Stanley Noneze,
Stella Yuen,
Steven J Libal,
Tara K Normandin,
Tej Poonai,
Thomas J Mooney,
Thomas Siebertz,
Valerie A Potopsingh,
Vanessa M Williams,
Wayne J Meyer,
Wendy M Stone,
William M Rennells,
William P Chilton,
Yuyan Liang
Joseph Milcetic's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2000 | FDA 483 | Novartis Pharmaceuticals Corp. - Form 483, 2000-11-16 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more